ROBOTIC SURGERY FOR GYNAECOLOGICAL CANCER
IN INDIA
The Complete Patient Guide — Medbot Toumai Dual Console | Precision | Training | Excellence
Robotic Cancer Surgery: The Most Precise Surgical Platform Available — Now in India
There are three ways to perform a hysterectomy for gynaecological cancer. The first is with a 20-centimetre incision through the abdominal wall, direct hands in the body, and 7–10 days in hospital. The second is with 4 small keyhole incisions, a camera, and laparoscopic instruments — same cancer result, 2–3 days in hospital. The third is with the same 4 small incisions, but with a robotic surgical platform giving the surgeon 3D vision at 10x magnification, instrument tips that bend and rotate in any direction inside the body, and electronic filtration of every involuntary hand tremor — 1–2 days in hospital.
All three approaches remove the same cancer. All achieve the same margins, the same lymph nodes, the same oncological result. But the third approach — robotic surgery — does it with the finest possible precision, the least possible blood loss, and the fastest possible recovery. For a woman who will start chemotherapy 3 weeks after robotic surgery rather than 7 weeks after open surgery, the platform chosen for her hysterectomy could matter to her cancer outcome — not just her comfort.
At Shree Hospitals in Mumbai, Dr. Jay Mehta — an Advanced Pelvic Surgeon who has performed and demonstrated live robotic cancer surgeries at international conferences across Europe, Asia, and the Middle East — leads India’s most advanced robotic gynaecological oncology programme. Operating the Medbot Toumai Dual Console — a dual-console robotic platform that makes Shree Hospitals a recognised robotic surgery training institute in India — Dr. Mehta brings world-class robotic cancer surgery to patients from across the country who deserve the best available care.
KEY FACTS AT A GLANCE
YES — robotic-assisted surgery is not only possible but is the most technologically advanced surgical approach available for gynecological cancer. Robotic surgery is performed through 4–5 incisions each less than 1cm, using robotic arms controlled by Dr. Jay Mehta from a dedicated surgical console. The Medbot Toumai Dual Console at Shree Hospitals is one of India’s most advanced robotic platforms for gynaecological oncology.
Shree Hospitals operates the Medbot Toumai Dual Console robotic surgical system — a dual-console platform that allows Dr. Jay Mehta (Lead Console) and a trainee surgeon (Teaching Console) to operate simultaneously. This dual-console design makes Shree Hospitals a recognised robotic surgery training institute in India — the only model that ensures advanced surgical training without compromising the lead surgeon’s control of the operation.
The Medbot Toumai provides 3D high-definition visualisation at ×10 magnification, 7-degree-of-freedom instrument movement (a wrist joint at the tip of every robotic instrument), and electronic tremor filtration — three technological features that are not available in standard laparoscopic surgery and that directly improve the quality of nerve-sparing parametrial dissection, sentinel lymph node removal, and fine pelvic dissection.
Robotic hysterectomy + lymphadenectomy for gynaecological cancer at Shree Hospitals results in average blood loss of 100–200 mL, hospital stay of 1–2 days, and return to normal activities in 2–3 weeks. These outcomes are the best available for equivalent cancer surgery — significantly better than laparoscopy (which is already dramatically better than open surgery).
The robotic surgical surcharge at Shree Hospitals is approximately ₹1.25 lakhs above the standard surgical package. This additional cost is partially offset by the reduced hospital stay (1–2 days vs 5–7 days for open surgery) — saving 3–5 nights of room charges. For a patient who values the fastest possible recovery and earliest return to chemotherapy, robotic surgery represents excellent value.
Multiple international comparative studies demonstrate that robotic radical hysterectomy, robotic staging for endometrial cancer, and robotic sentinel lymph node mapping all achieve equivalent cancer outcomes (equivalent lymph node yield, recurrence rates, and survival) to both laparoscopic and open surgery — with measurably superior outcomes for bladder function preservation through improved nerve-sparing.
Dr. Jay Mehta has performed and demonstrated live robotic gynaecological cancer surgeries at international conferences and hospitals across Europe, Asia, and the Middle East. His dual recognition — as both an advanced laparoscopic and robotic gynaecological oncologist — makes him one of the most comprehensively trained minimally invasive cancer surgeons in India.
Robotic surgery is particularly advantageous for obese patients with gynaecological cancer — who represent a large proportion of endometrial cancer patients. The robotic system’s longer instrument reach, superior 3D visualisation, and elimination of the fulcrum effect (instrument pivot constraint) make it technically superior to standard laparoscopy in obese patients with difficult pelvic access.
The Medbot Toumai Dual Console — Understanding the Technology That Operates on You
Every patient who chooses robotic surgery at Shree Hospitals deserves to understand the specific technology being used. The Medbot Toumai Dual Console is not just a surgical tool — it is a platform that defines the quality of every movement Dr. Mehta makes inside your body, every vessel he seals, every nerve he preserves. Understanding its capabilities transforms it from an intimidating piece of technology into a source of confidence.
Medbot Toumai Dual Console — Features, Capabilities, and Clinical Significance
| Medbot Toumai Dual Console Feature | What It Is and Why It Matters for Your Cancer Surgery |
|---|---|
| What is the Medbot Toumai Dual Console Robotic System? | The Medbot Toumai is a state-of-the-art surgical robotic platform featuring two fully functional operating consoles — a Lead Console (where Dr. Jay Mehta operates) and a Teaching Console (where a trainee surgeon or assistant can operate simultaneously). The system drives multi-jointed robotic arms — each holding a specialised surgical instrument — that are positioned above the patient in the operating theatre.The Medbot Toumai offers: 3D high-definition stereoscopic vision at ×10 surgical magnification; 7-degree-of-freedom (7DOF) instrument movement (replicating the full range of motion of the human wrist and hand at the instrument tip, inside the patient's body); tremor filtration (electronically eliminating the natural hand tremor that is unavoidable in open or standard laparoscopic surgery); and force feedback (the surgeon perceives tissue resistance through the console hand controllers).Shree Hospitals' Medbot Toumai Dual Console system was selected for its dual teaching capability — enabling live training of the next generation of robotic surgeons while maintaining the lead surgeon's complete control of every critical surgical step. |
| The Dual Console Advantage — Lead Console + Teaching Console | The dual-console architecture of the Medbot Toumai is what makes Shree Hospitals unique in India as a robotic surgery training institute for gynaecological oncology.LEAD CONSOLE (Dr. Jay Mehta): The primary surgeon's console. Dr. Mehta has complete, exclusive control of all four robotic arms. No movement occurs on the robotic arms without Dr. Mehta initiating it from his console. Patient safety is never compromised — the lead surgeon is always in full control.TEACHING CONSOLE: A second fully functional console where a trainee surgeon or visiting surgeon can observe, assist, or — with Dr. Mehta's deliberate handover — practice specific surgical steps under direct supervision. Dr. Mehta can instantly switch from Teaching Console input back to Lead Console control at any moment.For patients: the robotic surgery they receive is always performed by Dr. Mehta at the Lead Console. The Teaching Console enables Shree Hospitals to train other surgeons — but never at the expense of patient safety or surgical quality. |
| 7-Degree-of-Freedom (7DOF) Instruments — The Technical Revolution | Standard laparoscopic instruments are rigid and straight — they can be pushed, pulled, and rotated, but they have no wrist joint. The range of motion is limited by the 'fulcrum effect' (the instrument pivots at the port site, meaning hand movements are reversed and amplified inside the body).Robotic instruments have a wrist joint at their tip — allowing the instrument to bend and rotate within the body, independent of the port axis. This 7DOF movement replicates the natural dexterity of a surgeon's hand working directly in the surgical field.For nerve-sparing radical hysterectomy: the autonomic nerve fibres of the inferior |
| Medbot Toumai Dual Console Feature | What It Is and Why It Matters for Your Cancer Surgery |
|---|---|
| Standard laparoscopic instruments are rigid and straight — they can be pushed, pulled, and rotated, but they have no wrist joint. The range of motion is limited by the 'fulcrum effect' (the instrument pivots at the port site, meaning hand movements are reversed and amplified inside the body).Robotic instruments have a wrist joint at their tip — allowing the instrument to bend and rotate within the body, independent of the port axis. This 7DOF movement replicates the natural dexterity of a surgeon's hand working directly in the surgical field.For nerve-sparing radical hysterectomy: the autonomic nerve fibres of the inferior hypogastric plexus are 2–3mm threads running through the parametria — right next to the tissue that must be excised. Preserving these nerves requires tool manipulation in multiple planes simultaneously, around curves and angles that standard laparoscopy simply cannot achieve. The 7DOF robotic wrist makes this possible with a precision that is impossible with straight laparoscopic instruments. | |
| Tremor Filtration — Eliminating the Human Hand's Limitation | The human hand has a natural physiological tremor — small, involuntary movements at a frequency of 8–12 Hz. In open surgery, this tremor is absorbed by the mass of the tissues being handled. In laparoscopic surgery, long rigid instruments amplify this tremor — a 2mm hand tremor becomes a 4–6mm instrument tip movement inside the patient.The Medbot Toumai electronically filters out all hand tremor below a defined threshold. The instrument tip moves only in response to intentional surgeon movements — not involuntary tremors. For fine dissections close to nerves, ureters, and major vessels, this tremor elimination translates directly into reduced inadvertent injury risk and higher-quality surgical work. |
| 3D High-Definition Vision — Depth and Magnification | Standard laparoscopic cameras produce a 2D image — the surgeon sees the surgical field flattened onto a monitor. Depth perception comes from secondary visual cues (shadow, parallax) rather than from true stereoscopic vision.The Medbot Toumai provides true 3D stereoscopic vision — each eye of the surgeon (at the console eyepiece) receives a slightly different angle image from the dual-camera laparoscope, creating genuine depth perception. Combined with ×10 surgical magnification, this 3D view reveals anatomical structures — nerve fibres, lymphatic channels, vascular planes — that are simply not visible at ×1 naked-eye or ×4 standard laparoscopic magnification.For radical hysterectomy, this means: the ureter can be traced in 3D depth through the parametria; the autonomic nerve fibres can be distinguished from fibrous tissue; vascular pedicles can be precisely identified before being sealed and divided. |
Is Robotic Surgery Possible for Gynaecological Cancer?
Yes — robotic surgery is not only possible but represents the most technologically advanced surgical approach available for multiple gynaecological cancer indications. The decision about which cases benefit most from the robotic approach — and where standard laparoscopy or open surgery is equally appropriate — requires specialist assessment.
Robotic Surgery for Gynaecological Cancer — Which Cancers and Which Stages
| Cancer Type and Stage | Robotic Surgery? | Clinical Details | |
|---|---|---|---|
| Endometrial Cancer (Stage I–II) | YES — Gold Standard (Preferred Approach) | Robotic total hysterectomy + BSO + sentinel lymph node mapping with ICG fluorescence is the preferred surgical approach for Stage I–II endometrial cancer at Shree Hospitals. Large comparative studies (including the LAP2 robotic substudy and multiple cohort analyses) confirm equivalent cancer outcomes with the best recovery profile of any approach. Particularly advantageous in obese patients — the largest endometrial cancer demographic. | |
| Cervical Cancer (Stage IB1, IB2) | YES — With LACC Caveat (Maximally Invasive Technique) | Robotic radical hysterectomy (Type B and C, Querleu-Morrow) for early cervical cancer. The LACC trial findings (higher recurrence in minimally invasive radical hysterectomy vs open) are discussed with every patient. At Shree Hospitals, the no-manipulator technique and precise nerve-sparing enabled by robotic 7DOF instruments are the approach used for eligible patients. For tumours ≤2cm with no LVSI — robotic approach with no-manipulator technique is offered after individualised counselling. | |
| Central Cancer — Radical Trachelectomy | YES — Robotic Approach | Robotic radical trachelectomy (removing the cervix while preserving the uterus) is particularly suited to the robotic platform due to the complex, precise dissection required in the parametrial area close to the uterine isthmus. The 7DOF robotic instruments and 3D magnification make this fertility-preserving procedure safer and more precise than standard laparoscopy for appropriately selected patients. | |
| Ovarian Cancer (Staging) | YES — Robotic Staging Feasible | Robotic para-aortic lymphadenectomy extending to the level of the renal vessels is achievable by Dr. Mehta — requiring reposition of robotic arms or port reorganisation. The 7DOF instruments are particularly helpful for the fine dissection required around the aorta, vena cava, and renal vessels. | |
| Endometrial Cancer (Stage III–IV) | YES — Robotic Para-aortic Lymphadenectomy | Robotic-assisted surgical staging for apparent early ovarian cancer — oophorectomy, omentectomy, peritoneal biopsies, pelvic and para-aortic lymph node sampling, and washings. Robotic approach particularly useful for obese patients where standard laparoscopy is limited, and for complex adhesiolysis when prior surgeries have created pelvic adhesions. | |
| Advanced Ovarian Cancer (Stage III–IV Debulking) | LIMITED — Diagnostic Role Only | Robotic approach is generally not the platform for full cytoreductive surgery for advanced ovarian cancer — HIPEC and multi-visceral debulking require open access. However, robotic diagnostic laparoscopy for PCI scoring and biopsy before planned open debulking is feasible. | |
| Recurrent Gynaecological Cancer(Secondary Cytoreduction | SELECTIVE — Expert Assessment | Robotic secondary cytoreductive surgery for low-volume, localised recurrence is feasible at specialist centres. Adhesions from previous surgery increase complexity. Each case is assessed individually by Dr. Mehta. |
Benefits of Robotic Surgery vs Open and Laparoscopic Surgery
The three-way comparison — open vs laparoscopic vs robotic — is the most clinically useful framework for understanding where robotic surgery’s specific advantages lie. Not every metric favours robotics over laparoscopy (the cancer outcome is equivalent; the cost is higher). But in several specific domains, the robotic advantage is meaningful and evidence-based.
